Fennec Pharmaceuticals (FENC) Enterprise Value Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -15.66% |
| Sep 30, 2025 | 9.64% |
| Jun 30, 2025 | -7.84% |
| Mar 31, 2025 | -7.49% |
| Dec 31, 2024 | -8.07% |
| Sep 30, 2024 | -18.33% |
| Jun 30, 2024 | -16.41% |
| Mar 31, 2024 | -24.15% |
| Dec 31, 2023 | 24.10% |
| Sep 30, 2023 | 27.96% |
| Jun 30, 2023 | 27.18% |
| Mar 31, 2023 | -10.25% |
| Dec 31, 2022 | -20.32% |
| Sep 30, 2022 | -24.98% |
| Jun 30, 2022 | -3.00% |
| Mar 31, 2022 | 3.36% |
| Dec 31, 2021 | 2.52% |
| Sep 30, 2021 | 0.26% |
| Jun 30, 2021 | -2.10% |
| Mar 31, 2021 | -0.04% |
| Dec 31, 2020 | -2.40% |
| Sep 30, 2020 | -50.71% |
| Jun 30, 2020 | -55.84% |
| Mar 31, 2020 | -44.95% |
| Dec 31, 2019 | -51.49% |
| Sep 30, 2019 | -49.76% |
| Jun 30, 2019 | -39.01% |
| Mar 31, 2019 | -233.59% |
| Dec 31, 2018 | -189.18% |
| Sep 30, 2018 | -161.85% |
| Jun 30, 2018 | -140.03% |
| Mar 31, 2018 | -140.70% |
| Dec 31, 2017 | -130.52% |
| Sep 30, 2017 | -153.74% |
| Jun 30, 2017 | -116.02% |
| Mar 31, 2017 | -34.44% |
| Dec 31, 2016 | -33.15% |
| Sep 30, 2016 | -103.55% |
| Jun 30, 2016 | -71.52% |
| Mar 31, 2016 | 34.00% |
| Dec 31, 2015 | 25.77% |
| Sep 30, 2015 | 21.83% |
| Jun 30, 2015 | 19.74% |
| Mar 31, 2015 | 25.95% |
| Dec 31, 2014 | 24.20% |
| Sep 30, 2014 | 54.20% |
| Jun 30, 2014 | 46.98% |
| Mar 31, 2014 | 35.66% |
| Dec 31, 2013 | 34.61% |
| Sep 30, 2013 | 56.65% |
| Jun 30, 2013 | 47.98% |